Three independent studies, encompassing a combined sample size of 361 participants, consistently reported statistically significant elevations in NSE levels both in individuals with diabetes compared to healthy controls, and in individuals with diabetes who experienced ischemic stroke compared to diabetic individuals without stroke. This evidence concerns the gene ENO2 and diabetes mellitus.